Pharmaceutical Industry Information Portal

HomeDiscovery and Development

Discovery and Development

WHO’s Solidarity clinical trial enters a new phase with three new candidate drugs

The Solidarity PLUS trial is a platform trial that represents the largest global collaboration among WHO Member States.

Official data from leading countries confirms the Sputnik V vaccine’s high safety and efficacy profile

To date Sputnik V has been approved in 69 countries with total population exceeding 3.7 billion people - nearly half of the global population.

Pre-clinical trials of intranasal version of Sputnik V completed

The vaccine helps to develop a local immunity, therefore it will be most likely recommended to those who have contraindications to injections.

Combination of the Sputnik Light with others vaccines demonstrates high safety profile

Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik V – the world’s first registered vaccine against coronavirus.

Betuvax coronavirus vaccine clinical trials to begin in September

The Betuvax-CoV-2 is a split recombinant vaccine of the basis of spherical particles with the coronavirus surface antigen (protein).

Coronavirus mutations only slightly reduce vaccines’ efficacy

The mutations of the novel coronavirus cause only a marginal decrease in the efficacy of vaccines certified in Russia.
spot_img

Expert Articles

spot_img